Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus

Journal of the American College of Cardiology

Volumn 47, Issue 3, 2006, Pages 598-604

  Herrero, Pilar ^a   Peterson, Linda R ^b   McGill, Janet B ^b   Matthew, Stanley ^b   Lesniak, Donna ^a   Dence, Carmen ^a   Gropler, Robert J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LACTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GLUCOSE UTILIZATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LACTATE BLOOD LEVEL; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 1; FATTY ACIDS; FEMALE; GLUCOSE; HUMANS; INSULIN; LACTIC ACID; MALE; MYOCARDIUM; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY;

EID: 31644445201     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.09.030     Document Type: Article

References (47)

1. W.B. Kannel, D.L. McGee Diabetes and cardiovascular disease the Framingham study JAMA 241 1979 2035 2038
2. P. Koskinen, M. Manttari, V. Manninen, J.K. Huttunen, O.P. Heinonen, M.H. Frick Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study Diabetes Care 15 1992 820 825
3. R.D. Abbott, R.P. Donahue, W.B. Kannel, P.W. Wilson The impact of diabetes on survival following myocardial infarction in men vs. women JAMA 260 1988 3456 3460
4. W.B. Kannel, M. Hjortland, W.P. Castelli Role of diabetes in congestive heart failure the Framingham Study Am J Cardiol 34 1974 29 34
5. T.J. Regan, M.M. Lyons, S.S. Ahmed Evidence for cardiomyopathy in familial diabetes mellitus J Clin Invest 60 1977 885 899
6. P.J. Palumbo, C.R. Elveback, D.C. Conolly The Rochester Diabetes Project Coronary artery disease and congestive heart failure in the diabetic epidemiological aspects R.C. Scott Clinical Cardiology and Diabetes 1981 Futura New York, NY 13
7. J. Stamler, O. Vaccaro, J.D. Neaton, D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
8. B.E. Sobel Fibrinolysis and diabetes Front Biosci 8 2003 1085 1092
9. A. Nitenberg, P. Valensi, R. Sachs, M. Dali, E. Aptecar, J.R. Attali Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function Diabetes 42 1993 1017 1025
10. L. Poston, P.D. Taylor Endothelium-mediated vascular function in insulin-dependent diabetes mellitus Clin Sci 88 1995 245 255
11. J. Gerritsen, J.M. Dekker, B.J. TenVoorde Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease the Hoorn Study Diabetes Care 24 2001 1793 1798
12. P.J. Randle, E.A. Newsholme, P.B. Garland Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles Biochem J 93 1964 652 665
13. G.D. Lopaschuk, M. Spafford Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase 1 inhibition during reduction of coronary flow in acutely and chronically diabetic rats Circ Res 65 1989 378 387
14. D.D. Belke, T.S. Larsen, E.M. Gibbs, D.L. Severson Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice Am J Physiol 279 2000 E1104 E1113
15. Y. Zhou, P. Grayburn, A. Karim Lipotoxic heart disease in obese rats implications for human obesity Proc Natl Acad Sci USA 97 2000 1784 1789
16. T. Tsuji, K. Mizushige, T. Noma Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type 2 diabetic rat J Cardiovasc Pharmacol 38 2001 868 874
17. M.G. Gibala, M.E. Young, H. Taegtmeyer Anapleurosis in the citric acid cycle role in energy metabolism in heart and skeletal muscle Acta Physiol Scand 2000 657 665
18. I. Ungar, M. Gilbert, A. Siegel Studies on myocardial metabolism. IV. Myocardial metabolism in diabetes Am J Med 18 1955 385 396
19. A. Avogaro, R. Nosadini, A. Doria Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease Am J Physiol 258 1990 E606 E618
20. A. Doria, R. Nosadini, A. Avogaro, P. Fioretto, G. Crepaldi Myocardial metabolism in type 1 diabetic patients without coronary artery disease Diabet Med 8 1991 S104 S107
21. L. de las Fuentes, P. Herrero, L.R. Peterson, D.P. Kelly, R.J. Gropler, V.G. Davila-Roman Myocardial fatty acid metabolism independent predictor of left ventricular mass in hypertension and in left ventricular dysfunction Hypertension 41 2003 82 87
22. L.P. Peterson, A. Waggoner, P. Herrero Effect of obesity and insulin resistance on myocardial blood flow and substrate metabolism Circulation 109 2004 2191 2196
23. P. Soto, P. Herrero, R. Kowalski Impact of aging on dobutamine-induced changes in myocardial substrate utilization Am J Physiol 285 2003 H2158 H2164
24. S.R. Bergmann, P. Herrero, J. Markham Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography J Am Coll Cardiol 14 1989 639 652
25. H.H. Lee, V.G. Davila-Roman, J.F. Walsh, D.A. Delano, P.J. Rubin, R.J. Gropler The dependency of contractile reserve on myocardial blood flow implications for the assessment of myocardial viability by dobutamine stress echocardiography Circulation 96 1997 1885 1891
26. A. Buck, H.G. Wolpers, G.D. Hutchins Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET J Nucl Med 32 1991 1950 1957
27. 11C-glucose J Nucl Cardiol 9 2002 5 14
28. S.R. Bergmann, C.J. Weinheimer, J. Markham, P. Herrero Quantitation of myocardial fatty acid metabolism using positron emission tomography J Nucl Med 37 1996 1723 1730
29. C.R. Morgan, A. Lavora Immunoassay of insulin; two antibody system Diabetes 12 1963 115 120
30. J.R. Neely, M.J. Rovetto, J.F. Oram Myocardial utilization of carbohydrate and lipids Prog Cardiovasc Dis 15 1972 289 329
31. J.J. Luiken, Y. Arumugam, D.J. Dyck Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats J Biol Chem 276 2001 40567 40573
32. B. Desvergne, W. Wahli Peroxisome proliferator-activated receptors nuclear control of metabolism Endocr Rev 20 1999 649 688
33. P.M. Barger, D.P. Kelly PPAR signaling in the control of cardiac energy metabolism Trends Cardiovasc Med 10 2000 238 245
34. M.E. Young, S. Patil, J. Ying Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart FASEB J 15 2001 833 845
35. A.M. Kates, P. Herrero, C. Dence Impact of aging on substrate metabolism by the human heart J Am Coll Cardiol 41 2003 293 299
36. S.H. Li, J.H. McNeill In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats Mol Cell Biochem 217 2001 121 129
37. P. Razeghi, M.E. Young, T.C. Cockrill, O.H. Frazier, H. Taegtmeyer Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure Circulation 106 2002 407 411
38. 123I-heptadecanoic acid in subjects with impaired glucose tolerance Diabetologia 40 1997 541 549
39. J. Knuuti, T.O. Takala, K. Nagreen Myocardial fatty acid oxidation in patients with impaired glucose tolerance Diabetologia 44 2001 184 187
40. P. Nuutila, J. Knuuti, U. Ruotsalainen Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes Am J Physiol 258 1993 E756 E762
41. J. vom Dahl, W.H. Herman, R.J. Hicks Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography Circulation 88 1993 395 404
42. 18F-fluorodeoxyglucose for quantifying myocardial glucose utilization with positron emission tomography J Nucl Med 43 2002 1530 1541
43. S. Hadjadj, F. Pean, Y. Gallois Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy the Genesis France-Belgium Study Diabetes Care 27 2004 2661 2668
44. C. Lelliott, A.J. Vidal-Puig Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation Int J Obes Relat Metab Disord 28 2004 S22 S28
45. A.S. Neitzel, A.N. Carley, D.L. Severson Chylomicron and palmitate metabolism by perfused hearts from diabetic mice Am J Physiol Endocrinol Metab 284 2003 E357 E365
46. I. Yokoyama, T. Ohtake, S. Momomura Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension J Nucl Med 39 1998 884 889
47. L.D. Monti, C. Landoni, E. Setola Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in type 2 diabetic patients Am J Physiol 287 2004 H1225 H1231